GlassScriptPhysician profile
Pedro M Soler
NPI 1134128010
$1,322.78
in general payments reported to CMS, 2019-2025
11 companies · $215 in 2025
The $215 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $52.50 · 2021: $48.69 · 2022: $584 · 2023: $108 · 2024: $177 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Innovation Associates, INC. | $528.80 | 2022 | |
| Mentor Worldwide LLC | $356.18 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Merz North America, INC. | $230.81 | 2023-2025 | Xeomin |
| Tela Bio, INC. | $57.45 | 2019-2021 | |
| Integra Lifesciences Corporation | $44.22 | 2020-2023 | Durasorb Monofilament Mesh |
| Revance Therapeutics, INC. | $26.61 | 2025 | Daxxify |
| Innovation Technologies INC | $22.63 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $21.35 | 2025 | Exparel |
| Kerecis Limited | $16.11 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Abbvie INC. | $14.27 | 2024 | |
| Apyx Medical Corporation | $4.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pedro Soler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.